News & Events
1𝘾𝙚𝙡𝙡.𝘼𝙞 𝙎𝙝𝙤𝙬𝙘𝙖𝙨𝙚𝙨 𝘽𝙧𝙚𝙖𝙠𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙈𝙪𝙡𝙩𝙞-𝙊𝙢𝙞𝙘 𝙊𝙣𝙘𝙤𝙡𝙤𝙜𝙮 𝙄𝙣𝙨𝙞𝙜𝙝𝙩𝙨 𝘼𝙘𝙧𝙤𝙨𝙨 7 𝙎𝙩𝙪𝙙𝙞𝙚𝙨 𝙖𝙩 𝘼𝘼𝘾𝙍 2026
1Cell.Ai, a leader in precision oncology diagnostics, is proud to announce the presentation of seven research studies at the 𝘼𝙢𝙚𝙧𝙞𝙘𝙖𝙣 𝘼𝙨𝙨𝙤𝙘𝙞𝙖𝙩𝙞𝙤𝙣 𝙛𝙤𝙧 𝘾𝙖𝙣𝙘𝙚𝙧 𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝 (AACR) Annual Meeting 2026. These studies collectively demonstrate the power of
Join Us at AACR – April 17-22, 2026
Discover how 1Cell.Ai is advancing precision oncology at the intersection of science and technology Our team is leading the way with AI-powered, single cell multi-omic solutions designed to help in patient selection, therapy monitoring and
Beyond the Hype: The Real Bottlenecks in Breast Cancer Innovation
A Deep Dive into the Current Landscape of SERDs, ADCs, and Precision Oncology The pace of breast cancer drug development has never been faster. From the practice-changing durability of oral selective estrogen receptor degraders (SERDs)
AccuGenomics and 1Cell.Ai Partner to Bring Ultra-Sensitive Liquid Biopsy Testing Across Asia, with Plans for U.S. Expansion
Collaboration integrates per-sample NGS internal standards with multi-omic precision oncology platform to enhance cancer diagnostics accuracy and access WILMINGTON, N.C. and MUMBAI, India, Oct. 13, 2025 /PRNewswire/ — AccuGenomics, Inc., a US-based leader in next-generation sequencing (NGS)
Join Us at SABCS – San Antonio, TX | December 9–12
Booth #1446 – Discover our latest breast cancer research and AI-driven insights shaping precision oncology. Plan Your Visit to SABCS